ctrl K

Watchlist Price Alert

DICE Therapeutics Inc. (DICE)

NASDAQ: DICE · Real-Time Price · USD

47.55

0.03 (0.06%)

At close: Aug 08, 2023, 8:00 PM

DICE Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	1.13M	863K	5.78M
Cost of Revenue	n/a	n/a	n/a	n/a
Gross Profit	n/a	1.13M	863K	5.78M
Operating Income	-88.22M	-47.6M	-23.72M	-13.55M
Interest Income	5.21M	136K	139K	635K
Pretax Income	-83.89M	-48.96M	-23.74M	-12.94M
Net Income	-81.66M	-48.47M	-23.75M	-12.96M
Selling & General & Admin	25.66M	12.22M	5M	3.61M
Research & Development	62.56M	36.51M	19.58M	15.71M
Other Expenses	n/a	n/a	n/a	n/a
Operating Expenses	88.22M	48.73M	24.58M	19.32M
Interest Expense	679K	174K	13K	26K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	88.22M	48.73M	24.58M	19.32M
Income Tax Expense	-2.22M	-487K	13K	26K
Shares Outstanding (Basic)	39.4M	12.38M	23.23M	23.23M
Shares Outstanding (Diluted)	39.4M	12.38M	23.23M	23.23M
EPS (Basic)	-2.07	-3.91	-1.02	-0.56
EPS (Diluted)	-2.07	-3.91	-1.02	-0.56
EBITDA	-83.01M	-47.47M	-22.89M	-12.21M
EBIT	-83.21M	-48.78M	-23.73M	-12.91M
Depreciation & Amortization	5.21M	136K	836K	1.34M